The adoption of the market design rules by the European Parliament marks the finalisation of negotiations on the Clean Energy for All Europeans package.
New rules making the EU’s electricity market fit for the future and putting the consumer at the centre of the energy transition have been signed off by the European Parliament today – an important step in enabling the European Union and its Member States to embrace the clean energy transition, follow up on the already adopted 2030 climate legislation and meet the Paris Agreement commitments. With the completion of these last four legislative acts, the negotiations on the Clean Energy for All Europeans package are concluded and the EU is on the right path to decarbonise its economy in the second half of the century while maintaining its global competitiveness and creating growth and jobs.
Commissioner for Climate Action and Energy Miguel Arias Cañete said: “I thank the European Parliament for its strong support for the clean and fair energy transition, taking the EU a step closer towards delivering the Energy Union with citizens at its core, one of the key priorities President Juncker set out for this Commission. Today’s approval of the new electricity market design will make energy markets more flexible and facilitate the integration of a greater share of renewable energy. An integrated EU energy market is the most cost-effective way to ensure secure and affordable supplies to all EU citizens. I am particularly pleased that we have agreed on a common framework for capacity mechanisms that will ensure such mechanisms will be in line with our climate objectives in the future while taking into account legitimate security of supply concerns.”
Today the European Parliament completed the parliamentary approval of the new Electricity market Regulation and Electricity market Directive as well as of the Regulations on Risk Preparedness and on the Agency for the Cooperation of Energy Regulators (ACER). The Governance of the Energy Union Regulation the revised Energy Efficiency Directive, the revised Renewable Energy Directive and the Energy Performance of Buildings Directive have already entered into force last year.
The new electricity market design rules make the energy market fit for the future and place the consumer at the centre of the clean energy transition. The new rules are designed to empower energy consumers to play an active role in driving the energy transition and to fully benefit from a less centralised, and more digitalised and sustainable energy system. The new rules enable the active participation of consumers whilst putting in place a strong framework for consumer protection. By allowing electricity to move freely to where it is most needed, society will increasingly benefit from cross-border trade and competition to keep energy costs and prices in check. Capacity subsidies to power plants emitting more than 550gr CO2/kWh will be phased out under the new rules. The new market design also contributes to the EU’s goal of being the world leader in energy production from renewable energy sources by allowing more flexibility to accommodate an increasing share of renewable energy in the grid. The shift to renewables and increased electrification is crucial to achieve carbon neutrality by 2050.
Following this parliamentary approval, the Council of Ministers of the EU will have to formally approve the texts of the Directive and three Regulations, after which the new laws will be published in the Official Journal of the Union. The Regulations will enter into force immediately (with a date of application of 1 January 2020 for the Electricity Regulation) and the Directive will have to be transposed into national law within 18 months.
On 30 November 2016, the Commission proposed new rules (a revised Electricity market regulation and a revised Electricity market directive as well as a new Regulation on Risk Preparedness and a revised Regulation on the Agency for the Cooperation of Energy Regulators (ACER)) on the EU energy market design in order to help energy markets include more renewables, empower consumers, and better manage energy flows across the EU.
Markets need to be improved to meet the needs of renewable energies and attract investment in the resources, like energy storage, that can compensate for variable energy production. The market must also provide the right incentives for consumers to become more active and to contribute to keeping the electricity system stable. Today’s electricity market has fundamentally changed since 2009, when the most recent legislation was introduced. The share of electricity produced by renewables is expected to grow from 25% to 55% in 2030.
The proposed measures also contain measures that ensure that state interventions designed to make sure there is sufficient energy available are only used when really needed, and in a way that does not distort the internal electricity market.
Through the revised Directive, these new rules will put consumers at the heart of the transition – giving them more choice and greater protection. Consumers will be able to become active players in the market thanks to access to smart metres, price comparison tools, dynamic price contracts and citizens’ energy communities. At the same time, energy poor and vulnerable consumers will enjoy better protection.
The revised Electricity Regulation opens up electricity markets to renewables, energy storage and demand response, it brings stricter and harmonised rules for capacity mechanisms, reconciling thus the EU objectives of security of supply and emission reduction. Enhanced regional coordination will improve market functioning and thereby competitiveness while making the system more stable.
The Risk-preparedness Regulation increases the resilience of the EU electricity system and the Regulation on the Agency for the Cooperation of Energy Regulators (ACER) enhances ACER’s role of coordinating regulatory authorities of Member States.
Cocoon Technology Assists Dispensary Reopening With Launch of Contactless Self-Service Kiosks
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) and Cocoon Technology (“Cocoon”) are helping to define the new operating environment for contactless retail experiences with CocoonPod™ kiosks. As dispensaries begin the initial phases of reopening, they are required to follow guidelines maintaining the health and safety of both employees and customers. CocoonPod mitigates these safety concerns while reducing resource requirements.
The Cocoon team has observed the retail themes emerging from Covid-19. Dispensaries are adapting quickly in these challenging times having seen a loss of revenue and increased operational costs. By combining operational efficiency and social distancing measures, CocoonPod is ideally positioning dispensaries for safe reopening. CocoonPod enables customers to research products, place orders, and make payments directly through the kiosk or a mobile device. The entire transaction takes place while adhering to social distancing guidelines by alleviating the need for person-to-person contact at the point-of-sale.
CocoonPod ™ kiosks will be installed at all Thrive Cannabis Marketplace locations in Nevada starting in June with several additional Regional and National MSOs to follow. Cocoon is actively developing integrations to the most prominent ERP systems in North America allowing for maximum market penetration across all legal jurisdictions.
NewLeaf Brands Provides an Update to its Shareholders on Recent Corporate Developments and Shares a Positive Outlook
NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company“) a parent company operating innovative product divisions in the Naturally Sourced Therapies (NST) space, is delighted to provide its shareholders with a review of the recent milestones the Company has reached.
On April 9th, NewLeaf Brands’ wholly-owned subsidiary, We Are Kured, LLC (“Kured”) had launched its new CBD flower pre-rolled joints. The response from consumers was swift and overwhelmingly positive, with the Company now expecting to expand its distribution footprint within the United States to keep up with the high consumer demand.
Subsequently, on April 23rd, NewLeaf Brands had signed a share swap agreement with Levee Street Holdings, LLC (“Levee Street”) to purchase 50% of Levee Street for CAD $450,000 in common shares. Greg Kassanoff founded Levee Street to infiltrate the “alternative” beverage space, which includes CBD products and is the founder of Levee Street Holdings, LLC, Pioneer Wine & Spirits, LLC, & CEO of Mexcor Pioneer Wine & Spirits (“MPWS”). The latter, MPWS, has thousands of existing retail and restaurant relationships throughout the state of Texas with infrastructure to support various distribution efforts. Overall, Mr. Kassanoff’s vast network of accounts and relationships have been instrumental in deploying NewLeaf Brands’ suite of products into accounts all over the state of Texas and the Company expects to provide shareholders with further exciting updates in the very near future.
As the Company continues to seek novel routes for growth, Joshua Bartch, CEO of NewLeaf Brands said, “The whole team has been working around the clock to become a market leader in the various sectors the Company operates in, including the mushroom, hemp and cannabis space, and with our recent successes, we believe it’s time to review these updates with our dedicated shareholders.”
On April 29th, NewLeaf Brands had signed a definitive agreement to acquire Mydecine Group (“Mydecine”), a Colorado headquartered company. Mydecine is a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the plethora of compounds found in various varieties of mushrooms and the overall many uses of fungi. Founded by Damon Michaels and Rob Roscow, the Company, through its three wholly-owned divisions, “Mydecine Farms”, “Mydecine Wellness”, and “Mydecine Labs” aims to be an industry pioneer in the cultivation, processing, product development, and research and development of the many beneficial and exciting compounds and other uses that are found in various varieties of fungi from all around the world. Thanks to the tireless efforts of the entire team, NewLeaf Brands expects to announce earth shattering updates on the progress of Mydecine Group in the near future.
Not yet content with the stature of its cannabis and CBD business, NewLeaf Brands had signed a definitive agreement dated May 5th, 2020 with Trellis Holdings Oregon, LLC (“Trellis”) to acquire 37.5% of the issued and outstanding share capital of Trellis Holdings Oregon Op LLC (“Trellis”) from David Joshua Bartch and Benjamin Martch (the “Vendors”) by way of a share exchange (the “Transaction”), as was previously announced on February 6th, 2020. Trellis holds various licenses with the OLCC in the state of Oregon and operates in both the medical and recreational cannabis markets, maintaining an 11-acre recreational cultivation property in Southern Oregon and operating a medical and recreational cannabis dispensary in Portland, Oregon. Trellis has also recently applied for an additional license to increase its outdoor canopy cultivation capabilities by 40,000 sq. ft. while its greenhouse space was granted an additional 10,000 sq. ft. Overall, the Company expects to issue additional tantalizing updates on Trellis in the near future.
Subsequently, on May 11th and 12th, 2020, NewLeaf Brands appointed Damon Michaels to the position of Chief Operations Officer (COO) and Robert Roscow to the position of Chief Science Officer (CSO), respectively. Prior to Ebbu’s USD $429 MM acquisition by Canopy Growth, Mr. Michaels managed Ebbu’s day-to-day operations, including oversight of production, R&D, HR, compliance, supply chain, marketing and business development while also providing guidance for strategic business practices and strategy. Robert Roscow, on the other hand, was involved in running the world’s first cannabis genomic editing lab, focused on cannabinoid yield improvements, filing patents, establishing a cannabis tissue culture lab, and support of drug development team with statistical analysis and experimental design for Ebbu’s proprietary formulations. Since Mr. Michaels appointment, he has been incredibly active in the Company, utilizing his vast network of relationships and bringing his operational knowledge to the team while Mr. Roscow has spearheaded NewLeaf Brands’ biotech strategy through various partnerships and relationships that the Company expects to announce extremely soon, and which will put the Company drastically ahead of its competitors.
The Company then announced that Mydecine had begun work to build an ecosystem of resources targeted at unlocking the potential of fungi for human wellness as well as the build out of a specialty mycology lab in Denver, Colorado. The lab will serve Mydecine’s needs for the study, selection and cultivation of valuable and rare fungal products and will incorporate state of the art analytical chemistry, molecular biology, next-gen sequencing, and tissue culture. However, since the May 19th announcement, the scope of the project has increased drastically, and the Company intends to announce further updates on its progress in the near future.
Then, on May 21st, NewLeaf Brands signed a non-binding Letter of Intent (“LOI”) with MindLeap Health Inc. (“MindLeap”) pursuant to which NewLeaf Brands will acquire, by way of share exchange, 100% of all of the issued and outstanding securities of MindLeap, an arm’s length company. MindLeap is an advanced telemedicine digital health platform that helps people connect with mental health specialists that can empower them to thrive and develop habits for a healthy mind. While the NewLeaf Brands team has already made it through the due diligence phase, it is currently working on definitive negotiations, with the transaction expected to close soon.
The next day, May 22nd, a broker private placement led by Canaccord Genuity saw great success, as the offering closed and was heavily oversubscribed on the same day that it was opened. NewLeaf Brands is proud to have the full support of the Canaccord team and expects a long and fruitful relationship to develop between the two entities.
Lastly, on May 26th, the Company had appointed Dr. Aubrey Oliver ND, RBT to be its newest advisor. Dr. Oliver is a Jamaican registered Functional Holistic doctor and a graduate of Ashford University in Complementary and Alternative Medicine. In recent years, Dr. Oliver was the Coordinating Physician with Caribbean Clinical Research Associates on the first clinical research of its kind which dealt with CBD oil, nano liposome, and alcohol-based forms to find out the absorbency efficacy on healthy cells. Now, Mr. Oliver is spearheading the Company’s efforts to establish various resorts in the Caribbean country to house its unique and advanced psilocybin retreats. Partnering with industry’s top minds and authorities to bring project to fruition, NewLeaf Brands expects to issue numerous updates on the progress of these efforts soon.
Overall, NewLeaf Brands continues to position itself with an eye on the future, adding key personnel and business entities to its ever-growing cache of capabilities. And, in addition to thanking its loyal shareholders, the Company intends to share its crucial developments in the near term.
Global Biometrics Market in Healthcare to Witness a Four-fold Growth, Predicts Frost & Sullivan
Frost & Sullivan’s recent analysis, Global Biometrics in Healthcare Market, Forecast to 2024, predicts that the industry is likely to experience exponential growth over the next few years. By 2024, the market is estimated to witness a more than four-fold growth, reaching $2.72 billion, up from $670 million in 2019, at a compound annual growth rate (CAGR) of 32.3%.
For further information on this analysis, please visit: http://frost.ly/43n.
“The increase in adoption of electronic health records across the globe is the key market driver for biometrics in healthcare,” said Rajalingam Arikaarampalayam Chinnasamy, Industrial Project Manager at Frost & Sullivan. “Further, with the current COVID-19 crisis, adoption of non-intrusive and wearable biometric solutions in the healthcare industry will be more pronounced.”
Chinnasamy added: “Transition to as-a-service healthcare models will be the key growth area as it will be strongly supported by technological capabilities that enhance efficiency and value-added care services. Additionally, integration of advanced technologies such as artificial intelligence, blockchain, and machine learning will give a further push to next-generation biometric solutions because they enable and ensure robust and multilayered security for critical healthcare data.”
The initial high cost of biometrics deployment is one of the prominent factors restraining it from receiving immediate investments. However, government regulations for establishing electronic healthcare systems and databases, and the rise of digitization in the healthcare industry, will encourage healthcare market participants to adopt biometrics extensively, presenting immense growth prospects in various areas:
- The Biometrics-as-a-Service healthcare model will encourage healthcare market players to partner with third-party technology vendors to formulate plans to successfully implement software-centric biometric market offerings.
- Behavioral biometrics help establish an integrated biometric portfolio that offers multiple behavioral biometric tools that can be customized based on the level of security and accuracy required.
- Healthcare-as-a-Service aims to partner with wearable technology vendors to develop integrated market solutions, incorporating both front-end and back-end biometric applications.
- To curb healthcare data breaches, technology vendors should focus on multimodal biometric offerings and implementation of machine learning to ensure higher cybersecurity.
Global Biometrics in Healthcare Market, Forecast to 2024 is the latest addition to Frost & Sullivan’s Healthcare research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.
Cannabis4 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PharmaCielo Ltd. of Class Action Lawsuit and Upcoming Deadline – PCLOF
Cannabis3 weeks ago
Cronos Group Reports 2020 First Quarter Results
Cannabis3 weeks ago
Province of Ontario Issues Spyder Cannabis Retail Operator Licence
Cannabis4 weeks ago
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
Cannabis4 weeks ago
Sun Kissed’s Hakuna CEO Ilan Freeman’s Podcast Interview Discusses Acquisitions, Increased Profit Margins, 2020 Growth and Future Outlook
Cannabis2 weeks ago
Relay Medical and Fio Corporation Announce the Signing of MOU Agreement to Collaborate on a Rapid Diagnostic Testing Platform
Cannabis3 weeks ago
Hemp, Inc. Praises USDA’s Recently Announced Loan Guidance For Hemp Producers
Cannabis3 weeks ago
Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering